Major Depressive Disorder Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies -Axsome Therapeutics, AbbVie, Sage Therapeutics

DelveInsight's 'Major Depressive Disorder Market Insights, Epidemiology, and Market Forecast - 2032' report deliver an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of major depressive disorder in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Download Sample Report to know more @https://www.delveinsight.com/sample-request/major-depressive-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Major Depressive Disorder Overview
Major depressive disorder, also referred to as depression, is a serious medical illness that disrupts a person's mood, behavior, and thought processes, apart from degrading physical health. It should not be mistaken for the passing feelings of unhappiness that everyone experiences, nor should it be confused with the intense grief brought about by the death of a loved one. Sadness and grief are normal reactions to life stresses. With time, and usually, without medical treatment, sadness and grief lift, and people go on with their lives. By contrast, without specialized medical treatment, depression often persists. But with effective treatment, a large majority of people improve significantly. In most instances, major depressive disorder is a recurrent, episodic illness. This means that a person who has been depressed once and has recovered is likely to have one or more episodes of depression in the future, often within two to three years. When depression is not treated or is treated inappropriately, it is potentially fatal: nearly one in six people with severe, untreated depression commits suicide. However, seeking help and receiving an accurate diagnosis from a psychiatrist or other healthcare professional is a crucial and often decisive step toward recovery. Major depressive disorder is one form of depressive illness or mood disorder. Other forms include bipolar disorder (manic-depressive illness) and dysthymia. In bipolar disorder, episodes of depression alternate with episodes of mania, a condition in which inappropriate or extreme "high" feelings may lead to dangerous, destructive behavior. Dysthymia involves symptoms similar to those of major depressive disorder. The symptoms are milder but longer-lasting, and although they might not be disabling, they prevent a person from feeling good or operating at "full steam." Occasionally, a person with dysthymia may also have a major depressive disorder, a condition referred to as double depression.
Click here to learn more @https://www.delveinsight.com/report-store/major-depressive-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Major Depressive Disorder Market Report Key Facts
In 2021, the total 12-month prevalent cases of major depressive disorder (MDD) in the 7MM exceeded 48 million, out of which the highest 12-month prevalent cases were observed in the United States. The EU5 countries accounted for more than 20 million cases as a whole in 2021.
In 2021, there were more than 7 million mild cases, about 9 million moderate cases, and approximately 8 million severe cases of MDD in the United States. As per DelveInsight's assessments, the overall 12-month prevalence of severity-specific cases of MDD is expected to increase in the coming years
In 2021, there were more than 7 million mild cases, about 9 million moderate cases, and approximately 8 million severe cases of MDD in the United States. As per DelveInsight's assessments, the overall 12-month prevalence of severity-specific cases of MDD is expected to increase in the coming years.

Major Depressive Disorder Treatment Market The various major American and European guidelines for the treatment of depression provide similar basic treatment principles, including individualizing the treatment plan, preparing the patient for potential long-term treatment, providing measurement-based care, and treating to remission. The American Psychiatric Association (APA) updated its guideline for treating major depressive disorder. The new evidence-based guideline summarizes recommendations on the use of antidepressants and other drug therapies; psychotherapy, including cognitive behavior therapy; and Electroconvulsive Therapy.
Learn more about the treatment market @https://www.delveinsight.com/report-store/major-depressive-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
The Report Covers the Major Depressive Disorder Epidemiology Segmented by:
Major Depressive Disorder Gender-Specific Prevalent Cases
Major Depressive Disorder Severity Specific cases
Major Depressive Disorder Refractory Cases
Major Depressive Disorder 12 Months Prevalent Cases
Major Depressive Disorder Companies
Axsome Therapeutics
AbbVie
Sage Therapeutics
Luye Pharmaceuticals
Jansen Pharmaceuticals
And many others.
Learn more about the Key Companies and Emerging Therapies @https://www.delveinsight.com/report-store/major-depressive-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Table of Contents
Key Insights
Major Depressive Disorder Introduction
Executive Summary of Major Depressive Disorder
Disease Background and Overview
Epidemiology and patient population
Major Depressive Disorder Emerging Therapies
Major Depressive Disorder Market Outlook
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Report Methodology
DelveInsight Capabilities
Disclaimer

Learn about the detailed offerings of the report @https://www.delveinsight.com/report-store/major-depressive-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Related Reports

Major Depressive Disorder Epidemiology
https://www.delveinsight.com/report-store/major-depressive-disorder-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Major Depressive Disorder Pipeline Insights
https://www.delveinsight.com/report-store/major-depressive-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

DelveInsight Business Research LLP
Aditya Kaul
info@delveinsight.com
https://www.delveinsight.com

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.